找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Hepatitis C: Epidemiology, Prevention and Elimination; Volume 1 Angelos Hatzakis Book 2021 Springer Nature Switzerland AG 2021 pathogenesis

[復(fù)制鏈接]
樓主: Embolism
41#
發(fā)表于 2025-3-28 14:48:26 | 只看該作者
42#
發(fā)表于 2025-3-28 21:50:53 | 只看該作者
Laboratory Diagnosis,ection of HCV RNA to confirm an active infection. Assays that detect and quantify HCV core antigen provide an alternative to testing for HCV RNA. Molecular assays to quantify the HCV RNA load, determine the HCV genotype, and detect drug resistance-associated mutations are established in well-resourc
43#
發(fā)表于 2025-3-29 02:40:30 | 只看該作者
44#
發(fā)表于 2025-3-29 03:59:38 | 只看該作者
45#
發(fā)表于 2025-3-29 10:34:58 | 只看該作者
Natural History of Hepatitis C Infection,tive antiviral treatments allowed observational studies of large untreated cohorts. However, deep understanding of HCV natural history has been always hampered by the asymptomatic course of the disease, both in the acute and in the chronic infection phase. As a consequence, many studies conducted in
46#
發(fā)表于 2025-3-29 12:35:51 | 只看該作者
Epidemiology: Modeling of Natural History,hree important ingredients: disease stages, allowed transitions between stages, and corresponding stage-specific transition probabilities. This chapter reviews the approaches that have been used to model the natural history of chronic hepatitis C (CHC). A commonly used approach is to consider diseas
47#
發(fā)表于 2025-3-29 17:22:52 | 只看該作者
48#
發(fā)表于 2025-3-29 21:46:44 | 只看該作者
Hepatitis C Elimination and Advocacy Groups, of hepatitis C on the global public health agenda and resulted in the commitment by 193 countries to eliminate hepatitis C by 2030; and advocacy for viral hepatitis at a global level really began at a meeting of patient representatives from around the world in Barcelona in 2007.
49#
發(fā)表于 2025-3-30 03:01:03 | 只看該作者
HCV Elimination in Australia,d 1990s, followed by a decline in early- to mid-2000s, initially related to reduced heroin supply [1]. Ongoing HCV incidence of several 1000 infections/year over the last decade has been despite high-coverage harm-reduction services for people who inject drugs (PWID) [2].
50#
發(fā)表于 2025-3-30 04:28:33 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 03:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
云梦县| 常德市| 美姑县| 平南县| 东至县| 泰兴市| 探索| 科技| 东台市| 两当县| 来凤县| 松阳县| 呼和浩特市| 泰和县| 鲁甸县| 乐山市| 黄龙县| 于都县| 策勒县| 东明县| 连州市| 延边| 尉氏县| 永城市| 石泉县| 潜山县| 防城港市| 揭西县| 商城县| 随州市| 商南县| 黑水县| 普兰县| 和田市| 天等县| 鹤壁市| 金门县| 阜城县| 怀集县| 昭通市| 昌图县|